Aurora Cannabis announced today that Simona King, a former executive of Bristol Myers-Squibb, a multinational pharmaceutical company, has been appointed as Chief Financial Officer of the company, effective February 21, 2024.
King brings more than 25 years of progressive finance leadership experience, with deep business knowledge and proven success with global and emerging organizations. She served nearly 20 years with Bristol Myers-Squibb, where she held increasingly senior finance roles and enabled the company's growth strategy. Glen Ibbott, current Chief Financial Officer, will be stepping down from his full-time role effective today to pursue new opportunities. He will remain in an advisory role over the next few months to ensure a smooth transition of responsibilities to King.
Aurora also announces the completion of its previously announced consolidation of the common shares of the company on a 10 to 1 basis. The shares will begin trading on a post-consolidation basis on the NASDAQ Capital Market and the Toronto Stock Exchange (the "TSX") under the symbol "ACB" at the opening of trading today.
